Brainstorm Cell Therapeutics (NASDAQ:BCLI) Now Covered by StockNews.com
Equities research analysts at StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “hold” rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Stock Performance Shares of NASDAQ:BCLI opened at $1.22 on Tuesday. The company […]
Equities research analysts at StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “hold” rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Stock Performance Shares of NASDAQ:BCLI opened at $1.22 on Tuesday. The company […]
